Foundation Announces a Comprehensive, Two-Day Educational Experience for Founders of Early-Stage Medical Device, Therapeutics, Diagnostics and Digital Health Companies
Life science startups face more complex and daunting hurdles than new
enterprises in non-regulated industries do. To help aspiring and
early-stage life science entrepreneurs address these challenges, the
Ewing Marion Kauffman Foundation will hold a Kauffman Life Science
Ventures Summit June 22-23, 2012.
The Foundation announced a call for applications today for the
inaugural Summit, scheduled at the Mission Bay Conference Center at
the University of California-San Francisco.
"We surveyed early-stage and seasoned life science entrepreneurs to
find out what they considered critical needs for starting their
companies, and we built an agenda around their feedback," said
Dominique Pahud, director, advancing innovation at the Kauffman
Foundation. "We will answer the critical questions that founders must
address to start and grow viable life science companies. Every minute
of this event will focus on helping founders create a path to
successfully bring their innovations to market."
Industry experts and successful entrepreneurs will provide practical
guidance on commercializing innovations in each of four sectors:
medical device, therapeutics, diagnostics, and digital health.
Speakers and panelists representing each industry sector will share
lessons, advice and insights. Speakers include Steve Blank, serial
entrepreneur and author; Stephen Spielberg, deputy commissioner for
medical products and tobacco at the Food & Drug Administration; Paul
Yock, founder, Stanford Biodesign; Karl Handelsman, managing director,
CMEA Capital; Kim Popovits, CEO, Genomic Health; and more.
During the two-day Summit, participants will:
Up to 200 life science entrepreneurs across the four industry sectors
will be selected to attend. Applicants will be accepted based on two
factors: (1) how much they will benefit from the experience based on
where they are in their early-stage entrepreneurial journey, and (2)
the commercial viability of their plan.
The application and more information can be found at
The deadline is April 2, 2012. Selected applicants will be advised by
April 13, and registration will open April 14. The registration fee is
$100 before May 4, 2012, and $125 after that date. More information is
The Kauffman Life Science Ventures Summit is sponsored by the
California Institute for Quantitative Biosciences (qb3), Stanford
BioDesign, Rock Health and MIT's H@cking Medicine.
About the Kauffman FoundationThe Ewing Marion Kauffman Foundation is a
private nonpartisan foundation that works to harness the power of
entrepreneurship and innovation to grow economies and improve human
welfare. Through its research and other initiatives, the Kauffman
Foundation aims to open young people's eyes to the possibility of
entrepreneurship, promote entrepreneurship education, raise awareness
of entrepreneurship-friendly policies, and find alternative pathways
for the commercialization of new knowledge and technologies. In
addition, the Foundation focuses on initiatives in the Kansas City
region to advance students' math and science skills, and improve the
educational achievement of urban students, including the Ewing Marion
Kauffman School, a college preparatory charter school for middle and
high school students set to open in 2011. Founded by late entrepreneur
and philanthropist Ewing Marion Kauffman, the Foundation is based in
Kansas City, Mo. and has approximately $2 billion in assets. For more
information, visit www.kauffman.org(http://www.kauffman.org/), and
follow the Foundation on